Connection

THOMAS MONATH to Bacterial Vaccines

This is a "connection" page, showing publications THOMAS MONATH has written about Bacterial Vaccines.
Connection Strength

1.765
  1. Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun. 2001 Feb; 69(2):988-95.
    View in: PubMed
    Score: 0.168
  2. Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori. Vaccine. 1999 Aug 06; 17(23-24):3072-82.
    View in: PubMed
    Score: 0.151
  3. Oral immunization with recombinant Helicobacter pylori urease confers long-lasting immunity against Helicobacter felis infection. Vaccine. 1999 Mar 17; 17(11-12):1394-403.
    View in: PubMed
    Score: 0.147
  4. Immunization with recombinant Helicobacter pylori urease decreases colonization levels following experimental infection of rhesus monkeys. Vaccine. 1999 Mar 17; 17(11-12):1493-505.
    View in: PubMed
    Score: 0.147
  5. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med. 1998 Dec 21; 188(12):2277-88.
    View in: PubMed
    Score: 0.145
  6. Immunization against natural Helicobacter pylori infection in nonhuman primates. Infect Immun. 1998 Sep; 66(9):4340-6.
    View in: PubMed
    Score: 0.142
  7. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun. 1998 Jun; 66(6):2879-86.
    View in: PubMed
    Score: 0.140
  8. Vaccine development against infection with Helicobacter pylori. Br Med Bull. 1998; 54(1):229-41.
    View in: PubMed
    Score: 0.136
  9. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology. 1997 Oct; 113(4):1118-28.
    View in: PubMed
    Score: 0.133
  10. Evaluation of formalin-inactivated Clostridium difficile vaccines administered by parenteral and mucosal routes of immunization in hamsters. Infect Immun. 1995 Dec; 63(12):4619-27.
    View in: PubMed
    Score: 0.117
  11. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis. 1995 Jul; 172(1):161-72.
    View in: PubMed
    Score: 0.114
  12. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology. 2005 Mar; 128(3):764-70.
    View in: PubMed
    Score: 0.056
  13. Challenge model for Helicobacter pylori infection in human volunteers. Gut. 2004 Sep; 53(9):1235-43.
    View in: PubMed
    Score: 0.054
  14. Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A. Infect Immun. 2003 Mar; 71(3):1608-10.
    View in: PubMed
    Score: 0.048
  15. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology. 1999 Apr; 116(4):804-12.
    View in: PubMed
    Score: 0.037
  16. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun. 2002 Sep; 70(9):5096-106.
    View in: PubMed
    Score: 0.012
  17. Serum antitoxin antibodies mediate systemic and mucosal protection from Clostridium difficile disease in hamsters. Infect Immun. 1999 Feb; 67(2):527-38.
    View in: PubMed
    Score: 0.009
  18. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine. 1997 Mar; 15(4):370-6.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.